NCRI 2019 | Identifying the factors in gene regulatory networking in AML

Constanze Bonifer

Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, continues on the subject of sub-type specific aberrant transcriptional programming in acute myeloid leukemia (AML). Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

Share this video